TRINETI Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for TRINETI with the United States Patent and Trademark Office. The USPTO has given the TRINETI trademark a serial number of 97271830. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Johnson & Johnson. The TRINETI trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
trineti

General Information


Serial Number97271830
Word MarkTRINETI
Filing DateThursday, February 17, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events


Event DateEvent Description
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 21, 2022NEW APPLICATION ENTERED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 1, 2022ASSIGNED TO EXAMINER
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 8, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, March 20, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, June 22, 2023TTAB RELEASE CASE TO TRADEMARKS
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 22, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 2 FILED
Thursday, June 27, 2024SOU EXTENSION 2 GRANTED
Monday, January 22, 2024SOU EXTENSION 1 GRANTED
Monday, January 22, 2024SOU EXTENSION 1 FILED